Surgical Science Sweden AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0014428512
SEK
34.74
1.64 (4.95%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
884.09
882.85
802.54
366.78
104.80
101.52
65.70
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
884.09
882.85
802.54
366.78
104.80
101.52
65.70
Raw Material Cost
344.74
323.97
313.11
126.23
27.29
32.78
69.77
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
341.17
302.86
272.78
151.45
53.97
44.14
32.10
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
5.68
0.66
19.48
22.95
0.32
0.00
0.00
Selling and Distribution Expenses
213.57
203.61
162.02
94.43
40.59
43.99
0.00
Other Expenses
-17.05
-13.95
-12.77
-11.11
-3.78
-3.52
-3.21
Total Expenditure (Excl Depreciation)
734.68
691.57
639.68
284.00
84.33
85.67
69.77
Operating Profit (PBDIT) excl Other Income
149.4
191.29999999999998
162.89999999999998
82.8
20.5
15.8
-4.1
Other Income
14.64
77.63
70.80
34.48
-1.39
0.91
-0.00
Operating Profit (PBDIT)
224.56
324.53
277.29
143.55
29.32
31.94
-1.96
Interest
5.68
0.66
19.48
22.95
0.32
0.00
0.00
Exceptional Items
-0.28
0.00
-6.00
-28.50
0.90
-1.50
0.00
Gross Profit (PBDT)
539.35
558.89
489.43
240.55
77.51
68.73
-4.07
Depreciation
60.51
55.61
43.64
26.30
10.25
15.19
2.12
Profit Before Tax
158.09
268.26
208.17
65.80
19.66
15.25
-4.07
Tax
26.45
34.29
20.20
-20.44
4.05
2.65
0.45
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
131.65
233.97
187.97
86.25
15.61
12.60
-4.52
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
131.65
233.97
187.97
86.25
15.61
12.60
-4.52
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
131.65
233.97
187.97
86.25
15.61
12.60
-4.52
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.05
0.05
0.05
0.05
0.05
0.25
0.25
Reserves
4,828.64
4,345.21
4,236.45
3,585.07
427.05
401.68
79.38
Earnings per share (EPS)
2.58
4.59
3.69
2.02
0.45
0.43
-0.19
Diluted Earnings per share
2.58
4.59
3.69
2.02
0.45
0.43
-0.19
Operating Profit Margin (Excl OI)
16.9%
21.67%
20.29%
22.57%
19.53%
15.61%
-6.19%
Gross Profit Margin
24.73%
36.69%
31.38%
25.11%
28.54%
29.98%
-2.98%
PAT Margin
14.89%
26.5%
23.42%
23.52%
14.89%
12.41%
-6.88%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 0.14% vs 10.02% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -43.76% vs 24.47% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -14.99% vs 19.56% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 714.29% vs -96.41% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Surgical Science Sweden AB With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Net Sales
884.09
898.73
-14.64
-1.63%
Other Operating Income
0.00
0.00
0.00
Total Operating income
884.09
898.73
-14.64
-1.63%
Raw Material Cost
344.74
74.30
270.44
363.98%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
341.17
274.57
66.60
24.26%
Power Cost
0
0
0.00
Manufacturing Expenses
5.68
2.29
3.39
148.03%
Selling and Distribution Expenses
213.57
601.51
-387.94
-64.49%
Other Expenses
-17.05
-20.09
3.04
15.13%
Total Expenditure (Excl Depreciation)
734.68
751.82
-17.14
-2.28%
Operating Profit (PBDIT) excl Other Income
149.41
146.91
2.50
1.70%
Other Income
14.64
28.01
-13.37
-47.73%
Operating Profit (PBDIT)
224.56
185.75
38.81
20.89%
Interest
5.68
2.29
3.39
148.03%
Exceptional Items
-0.28
0.00
-0.28
Gross Profit (PBDT)
539.35
824.42
-285.07
-34.58%
Depreciation
60.51
10.83
49.68
458.73%
Profit Before Tax
158.09
172.62
-14.53
-8.42%
Tax
26.45
38.87
-12.42
-31.95%
Provisions and contingencies
0
0
0.00
Profit After Tax
131.65
133.75
-2.10
-1.57%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
131.65
133.75
-2.10
-1.57%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
131.65
133.75
-2.10
-1.57%
Equity Capital
0
0
0.00
Face Value
0.05
0.62
0.00
Reserves
4,828.64
727.46
4,101.18
563.77%
Earnings per share (EPS)
2.58
2.01
0.57
28.36%
Diluted Earnings per share
2.58
2.01
0.57
28.36%
Operating Profit Margin (Excl OI)
16.90%
16.35%
0.00
0.55%
Gross Profit Margin
24.73%
20.41%
0.00
4.32%
PAT Margin
14.89%
14.88%
0.00
0.01%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 88.41 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 0.14% vs 10.02% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 13.16 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -43.76% vs 24.47% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 20.99 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -14.99% vs 19.56% in Dec 2023

Annual - Interest
Interest 0.57 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 714.29% vs -96.41% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.90%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023